CHICAGO (GenomeWeb News) — Duke University’s Institute for Genome Sciences and Policy this fall will launch a prospective Phase IIb trial to learn whether a pharmacogenomic-based prognostic model can be used to change the way oncologists treat an early form of non-small cell lung cancer.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.